The purpose of this chapter is to provide the healthcare practitioner with detailed information on the existing oral and injectable (non-insulin) pharmacological options available for the treatment of patients with T2DM
Magyari et al., 2014), despite the difficulties encountered both in the data acquisition (duration, frequency, and intensity of exposure of the subjects, lifestyle habits) and in the interpretation of the results (Marrie, 2004)
doi: 10.1016/j.immuni.2005.03.004 162
If you need to cancel, please contact us immediately
A major role of the hormone is to regulate the glucose homeostasis in a glucose-dependent manner as a result of its insulinotropic and glucagonostatic actions
Understanding the differences in dosage and regulatory uses between these medications is crucial for achieving the desired outcomes